Lithium succinate
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
ATC code | D11AX04 (WHO) |
Identifiers | |
| |
PubChem (CID) | 10197702 |
ChemSpider | 8373202 |
ECHA InfoCard | 100.036.574 |
Chemical and physical data | |
Formula | C4H5LiO4 |
Molar mass | 124.02 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]
References
- ↑ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel). 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
- ↑ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.
This article is issued from Wikipedia - version of the 6/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.